+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Chronic Stable Angina - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Stable Angina - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Brain Ischemia - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Ischemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Arterial Thrombosis - Pipeline Insight, 2024 - Product Thumbnail Image

Arterial Thrombosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Deep Vein Thrombosis - Pipeline Insight, 2024 - Product Thumbnail Image

Deep Vein Thrombosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Venous Leg Ulcers - Pipeline Insight, 2024 - Product Thumbnail Image

Venous Leg Ulcers - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acute Coronary Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Coronary Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Angina Pectoris - Pipeline Insight, 2024 - Product Thumbnail Image

Angina Pectoris - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Venous Thromboembolism - Pipeline Insight, 2024 - Product Thumbnail Image

Venous Thromboembolism - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Hereditary Angioedema - Pipeline Insight, 2024 - Product Thumbnail Image

Hereditary Angioedema - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Arteriovenous fistula (AV) - Pipeline Insight, 2024 - Product Thumbnail Image

Arteriovenous fistula (AV) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Cardiogenic Shock - Pipeline Insight, 2024 - Product Thumbnail Image

Cardiogenic Shock - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Buerger's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Buerger's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Heart Failure - Pipeline Insight, 2024 - Product Thumbnail Image

Heart Failure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 300 Pages
  • Global
From
Aortic Stenosis - Pipeline Insight, 2024 - Product Thumbnail Image

Aortic Stenosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Pulmonary embolism - Pipeline Insight, 2024 - Product Thumbnail Image

Pulmonary embolism - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Intermittent Claudication - Pipeline Insight, 2024 - Product Thumbnail Image

Intermittent Claudication - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Post-Cardiac Arrest Syndrome (PCAS) - Pipeline Insight, 2024 - Product Thumbnail Image

Post-Cardiac Arrest Syndrome (PCAS) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
WAYLIVRA Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

WAYLIVRA Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
CSL112 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

CSL112 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more